156 related articles for article (PubMed ID: 34962906)
1. Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors.
Wakeman KM; Zhang QS; Bandhlish A; Cranmer LD; Ricciotti RW; Mantilla JG
Am J Clin Oncol; 2022 Jan; 45(1):28-35. PubMed ID: 34962906
[TBL] [Abstract][Full Text] [Related]
2. Federation Nationale des Centers de Lutte Contre le Cancer grading of soft tissue sarcomas on needle core biopsies using surrogate markers.
Lin X; Davion S; Bertsch EC; Omar I; Nayar R; Laskin WB
Hum Pathol; 2016 Oct; 56():147-54. PubMed ID: 27346575
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.
Jour G; Gullet A; Liu M; Hoch BL
Mod Pathol; 2015 Jan; 28(1):37-47. PubMed ID: 25059573
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival.
Lucas CG; Vasudevan HN; Chen WC; Magill ST; Braunstein SE; Jacques L; Dahiya S; Rodriguez FJ; Horvai AE; Perry A; Pekmezci M; Raleigh DR
Neurooncol Adv; 2020; 2(1):vdaa131. PubMed ID: 33880447
[TBL] [Abstract][Full Text] [Related]
5. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306.
Sugita S; Tanaka K; Oda Y; Nojima T; Konishi N; Machida R; Kita R; Fukuda H; Ozaki T; Hasegawa T
Jpn J Clin Oncol; 2024 Jun; 54(6):675-680. PubMed ID: 38391203
[TBL] [Abstract][Full Text] [Related]
7. Histopathological Spectrum of Soft-Tissue Tumors with Immunohistochemistry Correlation and FNCLCC grading: A North Indian Experience.
Singh HP; Grover S; Garg B; Sood N
Niger Med J; 2017; 58(5):149-155. PubMed ID: 31198267
[TBL] [Abstract][Full Text] [Related]
8. Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the Fédération Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems.
Khoury JD; Coffin CM; Spunt SL; Anderson JR; Meyer WH; Parham DM
Cancer; 2010 May; 116(9):2266-74. PubMed ID: 20166208
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative study.
Machado I; Cruz J; Righi A; Gambarotti M; Ferrari C; Ruengwanichayakun P; Giner F; Rausell N; Lavernia J; Sugita S; Najera L; Suarez L; Sanjuan X; García JAN; García Del Muro FJ; Gómez-Mateo MC; Valladares MM; Ramos-Oliver I; Romagosa C; Parafioriti A; Elisabetta A; di Bernardo A; Navarro S; Hasegawa T; Arana E; Llombart-Bosch A
Pathol Res Pract; 2021 Sep; 225():153562. PubMed ID: 34329836
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.
Hasegawa T; Yokoyama R; Lee YH; Shimoda T; Beppu Y; Hirohashi S
Oncology; 2000; 58(1):66-74. PubMed ID: 10644943
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors.
Nishida Y; Urakawa H; Nakayama R; Kobayashi E; Ozaki T; Ae K; Matsumoto Y; Tsuchiya H; Goto T; Hiraga H; Naka N; Takahashi S; Ando Y; Ando M; Kuwatsuka Y; Hamada S; Ueda T; Kawai A
Int J Cancer; 2021 Jan; 148(1):140-149. PubMed ID: 32638374
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and outcomes of patients with myxofibrosarcoma.
Look Hong NJ; Hornicek FJ; Raskin KA; Yoon SS; Szymonifka J; Yeap B; Chen YL; DeLaney TF; Nielsen GP; Mullen JT
Ann Surg Oncol; 2013 Jan; 20(1):80-6. PubMed ID: 22890594
[TBL] [Abstract][Full Text] [Related]
13. Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database.
Le Guellec S; Decouvelaere AV; Filleron T; Valo I; Charon-Barra C; Robin YM; Terrier P; Chevreau C; Coindre JM
Am J Surg Pathol; 2016 Jul; 40(7):896-908. PubMed ID: 27158754
[TBL] [Abstract][Full Text] [Related]
14. Expression of fibroblast growth factor receptor substrate 2 (FRS2) in primary retroperitoneal liposarcoma and its clinical implications.
Chen WD; Miao CL
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(13):6273-6281. PubMed ID: 37458641
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma.
Li Q; Zhuang R; Zhu J; Lu W; Hou Y; Liu J; Zhang Y; Wang Y; Liu T; Wang Z; Zhou Y
Future Oncol; 2015; 11(12):1759-66. PubMed ID: 26075444
[TBL] [Abstract][Full Text] [Related]
16. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.
Hagel C; Zils U; Peiper M; Kluwe L; Gotthard S; Friedrich RE; Zurakowski D; von Deimling A; Mautner VF
J Neurooncol; 2007 Apr; 82(2):187-92. PubMed ID: 17111191
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of H3K27 methylation status in malignant peripheral nerve sheath tumor: correlation with skeletal muscle differentiation.
Ito Y; Kohashi K; Endo M; Yoshimoto M; Ishihara S; Toda Y; Susuki Y; Kawaguchi K; Furukawa H; Tateishi Y; Yamada Y; Kinoshita I; Mori T; Yamamoto H; Nakashima Y; Oda Y
Virchows Arch; 2021 Dec; 479(6):1233-1244. PubMed ID: 34432163
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.
Mornex F; Resbeut M; Richaud P; Jung GM; Mirabel X; Marchal C; Lagrange JL; Rambert P; Chaplain G; Nguyen TD
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):651-9. PubMed ID: 7790251
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1.
Hwang IK; Hahn SM; Kim HS; Kim SK; Kim HS; Shin KH; Suh CO; Lyu CJ; Han JW
Cancer Res Treat; 2017 Jul; 49(3):717-726. PubMed ID: 28052660
[TBL] [Abstract][Full Text] [Related]
20. How long should we follow patients with soft tissue sarcomas?
Sawamura C; Matsumoto S; Shimoji T; Okawa A; Ae K
Clin Orthop Relat Res; 2014 Mar; 472(3):842-8. PubMed ID: 23716116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
